Trinity Gold Nutrition Capsules Recalled for Undeclared Drug Ingredients
Trinity Gold Nutrition capsules (Lot IN-030, expiring November 2027) have been recalled for containing three undeclared pharmaceutical ingredients: acetaminophen, diclofenac, and phenylbutazone. These unapproved drugs could cause health risks through medication interactions and adverse effects.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for undeclared pharmaceutical ingredients in a marketed product. While no illnesses or injuries have been reported, the presence of potent drugs not approved for this use poses a risk of harm through adverse effects or medication interactions.
Plain-English summary
Trinity Gold Nutrition capsules (60-capsule, 30-day supply format) distributed by Trinity Gold Nutrition of Fortmill, South Carolina have been recalled. The affected product has lot number IN-030 with an expiration date of November 2027 and UPC 802992001009. The product was manufactured in India.
The FDA initiated this recall because the product is marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), which are required for drug products. Laboratory analysis by the FDA determined that the product contains three undeclared pharmaceutical ingredients: acetaminophen, diclofenac, and phenylbutazone. These active drugs were not listed on the product label and pose potential health risks, particularly through interactions with other medications or adverse effects.
The product has been distributed to consumers nationwide within the United States, as well as to Canada, England, and Australia.
Consumers who have obtained this product should stop using it immediately and consult a healthcare provider, especially if they take other medications. Individuals who have consumed the product should seek medical attention if they experience any unusual symptoms. The product should be safely discarded or returned to the point of purchase.
The recalled product
- Product
- Trinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste. 2107, Fortmill, SC 29716, USA, Ph: 704-629-8203, www.trinitygold.com, Made in India, UPC 802992001009
- Manufacturer
- Trinity Gold Nutrition
- Category
- Drug — Dietary Supplement
- Hazard
- undeclared-pharmaceuticals
- acetaminophen
- diclofenac
- phenylbutazone
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: IN-030
- Exp. Date: NOV 2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27